We've paid the price, now let us work: Amrad boss
23 August, 2002 by Melissa TrudingerGently suggesting that analysts and investors should back off and let Amrad focus on its product development, managing director Sandra Webb presented Amrad as a case study on maturing public biotechnology companies at the AusBiotech 2002 conference.
CSIRO aims to strengthen its biotech focus
22 August, 2002 by Melissa TrudingerCSIRO has launched a biotechnology strategy in an attempt to strengthen its focus in the field.
Progen teams with CSIRO in manufacturing deal
20 August, 2002 by Pete YoungAustralia's largest contract drug manufacturer, Progen Industries, and CSIRO are marrying their bio-manufacturing skills.
Contract research organisations: labs for hire
19 August, 2002 by Pete YoungAs Australia's burgeoning young biotech hopefuls push toward clinical trials of their fledgling products, contract research organisations (CROs) are hoping for a rush of new business.
Cerylid appoints expat high-flyer to advisory board
19 August, 2002 by Iain ScottMelbourne-based Cerylid Biosciences has appointed another internationally experienced scientist to its advisory board.
Eiffel pleased with micronised insulin study
19 August, 2002 by Melissa TrudingerMelbourne-based Eiffel Technologies has announced that a pre-clinical study using micronised insulin demonstrated increased efficacy over native insulin.
Revenues expected, failures weren't, says Amrad boss
16 August, 2002 by Melissa TrudingerAmrad released its end of financial year report on Friday, saying that revenues and expenses were in line with forecasts.
New appointments boost BioDiem team
16 August, 2002 by Iain ScottMelbourne drug discovery company BioDiem has appointed two new executives as it gears up for a public listing.
Autogen means business with new appointment
16 August, 2002 by Melissa TrudingerVictorian biotech Autogen has appointed a business development director whose role will be to spark new collaborations and capitalise on its IP.
Danes, Australians collaborate on 'handmade clones'
16 August, 2002 by Melissa TrudingerAustralian and Danish scientists have developed a breakthrough new technique to clone animals they term "handmade cloning."
Scientist airs fears as SA gears up for GM debate
14 August, 2002 by Melissa TrudingerA gene technology moratorium bill proposed by South Australian Democrat Ian Gilfillan could stifle world-leading research in the state, a leading researcher has warned.
Sirtex opens another treatment centre in the US
13 August, 2002 by Melissa TrudingerSydney biotech Sirtex Medical has opened its fifth US-based cancer treatment centre since the Food and Drug Administration (FDA) approved the company's SIR-Spheres cancer therapy in March.
Norwood patent position grows apace
12 August, 2002 by Melissa TrudingerNorwood Abbey has been issued two more US patents for its proprietary drug delivery platform.
New program to study sheep genomics launched
12 August, 2002 by Melissa TrudingerMeat and Livestock Australia has launched a $15 million sheep genomics project to identify genes and develop tests for immunity to internal parasites and early diagnosis of Ovine Johnes and other diseases, increased efficiency of muscle growth, and improved reproduction.
Big pharma's big commitment
12 August, 2002 by Tanya HollisIn two years' time, a Federal government program credited with encouraging the injection of vital funds into Australian research and development will draw to a close.
